WO2003010176A3 - Complexes acide nucleique-proteine - Google Patents

Complexes acide nucleique-proteine Download PDF

Info

Publication number
WO2003010176A3
WO2003010176A3 PCT/GB2002/003351 GB0203351W WO03010176A3 WO 2003010176 A3 WO2003010176 A3 WO 2003010176A3 GB 0203351 W GB0203351 W GB 0203351W WO 03010176 A3 WO03010176 A3 WO 03010176A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
nucleic acid
acid complexes
complexes
assemble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2002/003351
Other languages
English (en)
Other versions
WO2003010176A2 (fr
Inventor
Mikhail Soloviev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to AU2002317380A priority Critical patent/AU2002317380A1/en
Publication of WO2003010176A2 publication Critical patent/WO2003010176A2/fr
Publication of WO2003010176A3 publication Critical patent/WO2003010176A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Chemical & Material Sciences (AREA)
  • Composite Materials (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des techniques de production de protéines de recombinaison qui s'auto-assemblent en complexes avec des acides nucléiques en solution ou sur des supports et des complexes acide nucléique-protéine produits selon cette technique, par exemple dans une structure de jeu ordonné d'échantillon.
PCT/GB2002/003351 2001-07-24 2002-07-23 Complexes acide nucleique-proteine Ceased WO2003010176A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002317380A AU2002317380A1 (en) 2001-07-24 2002-07-23 Protein-nucleic acid complexes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0118031.4 2001-07-24
GB0118031A GB0118031D0 (en) 2001-07-24 2001-07-24 Self assembled protein nucleic acid complexes and self assembled protein arrays

Publications (2)

Publication Number Publication Date
WO2003010176A2 WO2003010176A2 (fr) 2003-02-06
WO2003010176A3 true WO2003010176A3 (fr) 2003-12-31

Family

ID=9919095

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/003351 Ceased WO2003010176A2 (fr) 2001-07-24 2002-07-23 Complexes acide nucleique-proteine

Country Status (3)

Country Link
AU (1) AU2002317380A1 (fr)
GB (1) GB0118031D0 (fr)
WO (1) WO2003010176A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11845979B2 (en) 2020-06-02 2023-12-19 10X Genomics, Inc. Spatial transcriptomics for antigen-receptors

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4761202B2 (ja) * 2003-01-31 2011-08-31 学校法人慶應義塾 切断可能な対応付け分子およびそれを用いるスクリーニング方法
US8148302B2 (en) * 2005-10-19 2012-04-03 The United States Of America As Represented By The Department Of Health And Human Services In situ assembling of protein microarrays
US9085798B2 (en) 2009-04-30 2015-07-21 Prognosys Biosciences, Inc. Nucleic acid constructs and methods of use
WO2011071943A1 (fr) * 2009-12-07 2011-06-16 Prognosys Biosciences, Inc. Matrices de présentation de peptide
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
WO2011127099A1 (fr) 2010-04-05 2011-10-13 Prognosys Biosciences, Inc. Tests biologiques à codage spatial
EP2694709B1 (fr) 2011-04-08 2016-09-14 Prognosys Biosciences, Inc. Constructions peptidiques et systèmes d'essai
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
GB2500243A (en) * 2012-03-15 2013-09-18 Isogenica Ltd Identifying members of immobilised peptide libraries comprising protein-DNA complexes
EP4592400A3 (fr) 2012-10-17 2025-10-29 10x Genomics Sweden AB Procédés et produits pour optimiser la detection localisée ou spatiale de l'expression génique dans un échantillon de tissu
EP3736573A1 (fr) 2013-03-15 2020-11-11 Prognosys Biosciences, Inc. Procédés de détection de liaison peptide/mhc/tcr
CA2916662C (fr) 2013-06-25 2022-03-08 Prognosys Biosciences, Inc. Procedes et systemes pour determiner des motifs spatiales de cibles biologiques dans un echantillon
US10288608B2 (en) 2013-11-08 2019-05-14 Prognosys Biosciences, Inc. Polynucleotide conjugates and methods for analyte detection
EP3901282B1 (fr) 2015-04-10 2023-06-28 Spatial Transcriptomics AB Analyse de plusieurs acides nucléiques spatialement différenciés de spécimens biologiques
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
WO2020123316A2 (fr) 2018-12-10 2020-06-18 10X Genomics, Inc. Procédés de détermination d'un emplacement d'un analyte biologique dans un échantillon biologique
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
WO2020243579A1 (fr) 2019-05-30 2020-12-03 10X Genomics, Inc. Procédés de détection de l'hétérogénéité spatiale d'un échantillon biologique
WO2021091611A1 (fr) 2019-11-08 2021-05-14 10X Genomics, Inc. Agents de capture d'analytes marqués spatialement pour le multiplexage d'analytes
WO2021092433A2 (fr) 2019-11-08 2021-05-14 10X Genomics, Inc. Amélioration de la spécificité de la liaison d'un analyte
ES2982420T3 (es) 2019-12-23 2024-10-16 10X Genomics Inc Métodos para el análisis espacial mediante el uso de la ligazón con plantilla de ARN
CN115135984B (zh) 2019-12-23 2025-12-23 10X基因组学有限公司 可逆固定试剂及其使用方法
EP4081656A1 (fr) 2019-12-23 2022-11-02 10X Genomics, Inc. Compositions et méthodes d'utilisation d'échantillons biologiques fixés dans des dosages basés sur des compartiments
US12365942B2 (en) 2020-01-13 2025-07-22 10X Genomics, Inc. Methods of decreasing background on a spatial array
US12405264B2 (en) 2020-01-17 2025-09-02 10X Genomics, Inc. Electrophoretic system and method for analyte capture
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US20210230681A1 (en) 2020-01-24 2021-07-29 10X Genomics, Inc. Methods for spatial analysis using proximity ligation
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
US12076701B2 (en) 2020-01-31 2024-09-03 10X Genomics, Inc. Capturing oligonucleotides in spatial transcriptomics
US12110541B2 (en) 2020-02-03 2024-10-08 10X Genomics, Inc. Methods for preparing high-resolution spatial arrays
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
WO2021158925A1 (fr) 2020-02-07 2021-08-12 10X Genomics, Inc. Évaluation quantitative et automatisée de la performance de perméabilisation pour la transcriptomique spatiale
US11835462B2 (en) 2020-02-11 2023-12-05 10X Genomics, Inc. Methods and compositions for partitioning a biological sample
US12281357B1 (en) 2020-02-14 2025-04-22 10X Genomics, Inc. In situ spatial barcoding
US12399123B1 (en) 2020-02-14 2025-08-26 10X Genomics, Inc. Spatial targeting of analytes
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
US11926863B1 (en) 2020-02-27 2024-03-12 10X Genomics, Inc. Solid state single cell method for analyzing fixed biological cells
US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis
EP4139485B1 (fr) 2020-04-22 2023-09-06 10X Genomics, Inc. Procédés d'analyse spatiale utilisant un appauvrissement d'arn ciblée
US12416603B2 (en) 2020-05-19 2025-09-16 10X Genomics, Inc. Electrophoresis cassettes and instrumentation
EP4153776B1 (fr) 2020-05-22 2025-03-05 10X Genomics, Inc. Analyse spatiale pour détecter des variants de séquence
EP4414459B1 (fr) 2020-05-22 2025-09-03 10X Genomics, Inc. Mesure spatio-temporelle simultanée de l'expression génique et de l'activité cellulaire
WO2021242834A1 (fr) 2020-05-26 2021-12-02 10X Genomics, Inc. Procédé de réinitialisation d'un réseau
US12265079B1 (en) 2020-06-02 2025-04-01 10X Genomics, Inc. Systems and methods for detecting analytes from captured single biological particles
AU2021283174A1 (en) 2020-06-02 2023-01-05 10X Genomics, Inc. Nucleic acid library methods
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
EP4421186B1 (fr) 2020-06-08 2025-08-13 10X Genomics, Inc. Procédés de détermination d'une marge chirurgicale et procédés d'utilisation de ceux-ci
WO2021252747A1 (fr) 2020-06-10 2021-12-16 1Ox Genomics, Inc. Procédés de distribution de fluide
EP4165207B1 (fr) 2020-06-10 2024-09-25 10X Genomics, Inc. Methode pour determiner la position d'un analyte dans un echantillon biologique
US12435363B1 (en) 2020-06-10 2025-10-07 10X Genomics, Inc. Materials and methods for spatial transcriptomics
ES2994976T3 (en) 2020-06-25 2025-02-05 10X Genomics Inc Spatial analysis of dna methylation
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US12209280B1 (en) 2020-07-06 2025-01-28 10X Genomics, Inc. Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
US12553898B1 (en) 2020-08-10 2026-02-17 10X Genomics, Inc. Fluorescent hybridization of antibody-oligonucleotide for multiplexing and signal amplification
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
WO2022061150A2 (fr) 2020-09-18 2022-03-24 10X Geonomics, Inc. Appareil de manipulation d'échantillons et procédés d'enregistrement d'images
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
EP4729631A2 (fr) 2020-12-21 2026-04-22 10X Genomics, Inc. Procédés, compositions et systèmes de capture de sondes et/ou de codes à barres
EP4421491A3 (fr) 2021-02-19 2024-11-27 10X Genomics, Inc. Procédé d'utilisation d'un dispositif de support d'analyse modulaire
AU2022238446A1 (en) 2021-03-18 2023-09-07 10X Genomics, Inc. Multiplex capture of gene and protein expression from a biological sample
EP4305196B1 (fr) 2021-04-14 2025-04-02 10X Genomics, Inc. Procédés de mesure d'une mauvaise localisation d'un analyte
EP4320271B1 (fr) 2021-05-06 2025-03-19 10X Genomics, Inc. Procédés pour augmenter la résolution d'une analyse spatiale
WO2022256503A1 (fr) 2021-06-03 2022-12-08 10X Genomics, Inc. Procédés, compositions, kits et systèmes pour améliorer la capture d'analytes pour une analyse spatiale
US12553805B2 (en) 2021-08-02 2026-02-17 10X Genomics, Inc. Methods of preserving a biological sample
WO2023034489A1 (fr) 2021-09-01 2023-03-09 10X Genomics, Inc. Procédés, compositions et kits pour bloquer une sonde de capture sur un réseau spatial
WO2023086880A1 (fr) 2021-11-10 2023-05-19 10X Genomics, Inc. Procédés, compositions et kits pour déterminer l'emplacement d'un analyte dans un échantillon biologique
WO2023102118A2 (fr) 2021-12-01 2023-06-08 10X Genomics, Inc. Procédés, compositions et systèmes pour la détection améliorée d'analytes in situ et analyse spatiale
WO2023122033A1 (fr) 2021-12-20 2023-06-29 10X Genomics, Inc. Auto-test pour dispositif d'imagerie
EP4482979B1 (fr) 2022-11-09 2025-10-01 10X Genomics, Inc. Procédés, compositions et kits pour déterminer l'emplacement de plusieurs analytes dans un échantillon biologique
WO2025179207A1 (fr) * 2024-02-21 2025-08-28 Enterprise Science Fund, Llc Synthèse de peptides artificiels

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011922A1 (fr) * 1993-10-29 1995-05-04 Affymax Technologies N.V. Banques de presentation de peptides et d'anticorps in vitro
WO1998023781A1 (fr) * 1996-11-26 1998-06-04 Johns Hopkins University Systeme de detection de ligands et procedes d'utilisation associes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011922A1 (fr) * 1993-10-29 1995-05-04 Affymax Technologies N.V. Banques de presentation de peptides et d'anticorps in vitro
WO1998023781A1 (fr) * 1996-11-26 1998-06-04 Johns Hopkins University Systeme de detection de ligands et procedes d'utilisation associes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRADBURY A: "Evolution of the display technologies", TRENDS IN BIOTECHNOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 18, no. 5, May 2000 (2000-05-01), pages 183 - 184, XP004195994, ISSN: 0167-7799 *
CEBE REGIS ET AL: "Size of the ligand complex between the N-terminal domain of the gene III coat protein and the non-infectious phage strongly influences the usefulness of in vitro selective infective phage technology", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, vol. 352, no. 3, 2000, pages 841 - 849, XP002211404, ISSN: 0264-6021 *
DOI N ET AL: "STABLE: protein-DNA fusion system for screening of combinatorial protein libraries in vitro", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 457, no. 2, 27 August 1999 (1999-08-27), pages 227 - 230, XP004260157, ISSN: 0014-5793 *
NILSSON MIKAEL T I ET AL: "Functional expression and affinity selection of single-chain Cro by phage display: Isolation of novel DNA-binding proteins.", PROTEIN ENGINEERING, vol. 13, no. 7, July 2000 (2000-07-01), pages 519 - 526, XP002233554, ISSN: 0269-2139 *
STRICKER N L ET AL: "USING THE LAC REPRESSOR SYSTEM TO IDENTIFY INTERACTING PROTCINS", METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC, SAN DIEGO, CA, US, vol. 303, 1999, pages 451 - 468, XP000943989, ISSN: 0076-6879 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11845979B2 (en) 2020-06-02 2023-12-19 10X Genomics, Inc. Spatial transcriptomics for antigen-receptors

Also Published As

Publication number Publication date
WO2003010176A2 (fr) 2003-02-06
AU2002317380A1 (en) 2003-02-17
GB0118031D0 (en) 2001-09-19

Similar Documents

Publication Publication Date Title
WO2003010176A3 (fr) Complexes acide nucleique-proteine
WO2004022593A3 (fr) Evolution rationnelle de cytokines pour une plus grande stabilite, les cytokines et molecules d'acide nucleique codant
WO2005118719A3 (fr) Production d'acide 3-hydroxypropionique au moyen de $g(b)-alanine/pyruvate aminotransferase
WO2002046429A3 (fr) Polypeptides possedant une activite glucoamylase et acides nucleiques codant pour
WO2001029222A3 (fr) Polypeptides ayant une activite phospholipase b et acides nucleiques codant ces derniers
WO2001034646A3 (fr) Gelatines de recombinaison
WO2003089598A3 (fr) Polypeptides a activite xyloglucanase, et acides nucleiques codant ceux-ci
WO2002062999A8 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2003030821A3 (fr) Proteines de fusion d'albumine
WO2005047459A3 (fr) Acides nucleiques du sars, proteines, anticorps et utilisations associees
WO2002070647A3 (fr) Proteines oligomeres semblables a une chaperone, stables face aux denaturants et/ou resistant a la protease, polynucleotides codant les memes proteines et utilisations correspondantes
WO2001072689A3 (fr) Procede de separation d'un acide amine basique a partir d'un bouillon de fermentation
WO2003040681A3 (fr) Genes codant des proteines de la voie metabolique
WO2001098469A3 (fr) Polypeptides presentant une activite de la peroxydase et acides nucleiques codant pour ces polypeptides
WO2000041509A3 (fr) Polypeptides possedant une activite de phosphatase acide et acides nucleiques codant pour ceux-ci
WO2005012498A3 (fr) Production de porphyrines
WO2003040291A3 (fr) Genes codant pour des proteines du metabolisme du carbone et de production d'energie
WO2003029457A1 (fr) Procede de production d'acide amine
AU2002221164A1 (en) (r)-hydroxycarboxylic acid producing recombinant microorganism and process for preparing (r)-hydroxycarboxylic acid using the same
CA2243578A1 (fr) Acides nucleiques ligands a forte affinite pour les proteines du systeme complementaire
WO2001053339A3 (fr) Proteines de surface specifiques de l'oeuf
AU2002250254A1 (en) Nucleic acids, proteins, and antibodies
WO2003040292A3 (fr) Genes codant pour des proteines de synthese membranaire et de transport membranaire
WO2003040293A3 (fr) Genes codant des proteines de resistance et de tolerance au stress
EP1249443A3 (fr) Procédé de préparation de hydroxybenzoates de benzyle

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP